Invention Grant
US09334314B2 Peptide compounds derived from melanotransferrin and uses thereof
有权
衍生自黑色素转铁蛋白的肽化合物及其用途
- Patent Title: Peptide compounds derived from melanotransferrin and uses thereof
- Patent Title (中): 衍生自黑色素转铁蛋白的肽化合物及其用途
-
Application No.: US14352600Application Date: 2012-10-18
-
Publication No.: US09334314B2Publication Date: 2016-05-10
- Inventor: Richard Béliveau , Jonathan Michaud-Levesque , Krishna G. Peri , Abdelkrim Habi , Nathalie Bousquet-Gagnon
- Applicant: Theratechnologies Inc.
- Applicant Address: CA Montreal
- Assignee: THERATECHNOLOGIES INC.
- Current Assignee: THERATECHNOLOGIES INC.
- Current Assignee Address: CA Montreal
- Agency: Fish & Richardson P.C.
- International Application: PCT/CA2012/050741 WO 20121018
- International Announcement: WO2013/056372 WO 20130425
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K14/47 ; C07K14/79 ; A61K38/40
Abstract:
Peptide compounds derived from human melanotransferrin, and compositions thereof, are described. Uses of these peptide compounds, for example to modulate angiogenesis and/or cell migration, and/or to treat angiogenesis-related disorders (e.g., cancer), are also described.
Public/Granted literature
- US20150133385A1 PEPTIDE COMPOUNDS DERIVED FROM MELANOTRANSFERRIN AND USES THEREOF Public/Granted day:2015-05-14
Information query
